Conmed (CNMD) Return on Invested Capital (2011 - 2026)

Conmed's Return on Invested Capital history runs 16 years deep, the most recent figure standing at 0.08% for Q1 2026.

• Quarterly Return on Invested Capital fell 60.0% year-over-year to 0.08% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.08% (down 60.0% YoY) and the FY2025 annual result came in at 1.51%, down 380.0% from the prior year.
• Return on Invested Capital was 0.08% for Q1 2026 at Conmed, up from 0.37% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.57% in Q4 2024 and bottomed at 0.37% in Q4 2025.
• A 5-year average of 0.1% and a median of 0.02% in 2022 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2024 — Return on Invested Capital soared 58 bps — and 2025, when it sank 95 bps.
• Conmed's Return on Invested Capital stood at 0.07% in 2022, then sank by 106 bps to 0.0% in 2023, then soared by 12760 bps to 0.57% in 2024, then tumbled by 165 bps to 0.37% in 2025, then surged by 79 bps to 0.08% in 2026.
• Business Quant data shows CNMD's Return on Invested Capital at 0.08% in Q1 2026, 0.37% in Q4 2025, and 0.31% in Q3 2025.